Novartis Investigative Site

Guangdong, Guangzhou 510091

0 studies enrolling now · 1 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines — Completed